• Get a Complimentary Issue
  • Latest Issue
  • Login
Skip to navigation Skip to content BioInvest BioInvest Menu
  • About Us
    • Our Analysts
      • John McCamant
      • Jay Silverman
      • Jim McCamant
    • MTSL
    • BioInvest In The News
    • Whitepapers
    • Conference Calls
  • Recommended Portfolio
    • Portfolio Overview
      • Acadia (ACAD)
      • Alaunos (TCRT)
      • Alkermes (ALKS)
      • Bicycle (BCYC)
      • BioMarin (BMRN)
      • Celldex (CLDX)
      • Esperion (ESPR)
      • Incyte (INCY)
      • Ionis (IONS)
      • Madrigal (MDGL)
      • Myovant (MYOV)
      • Pacira (PCRX)
      • Precigen (PGEN)
      • Sangamo (SGMO)
      • Skye Bioscience (SKYE)
      • Vaxart (VXRT)
      • Viking Therapeutics (VKTX)
    • Portfolio Updates
    • CEO Insights
  • MTSL
    • MTSL Archives
    • Subscribe to the MTSL
  • SUBSCRIBE NOW
  • Get a Complimentary Issue
  • Subscribe to the MTSL
  • Login
  • Access Latest Issue
  • About Us
    • MTSL
      • Latest Issue
      • MTSL Archives
    • Our Analysts
      • John McCamant
      • Jay Silverman
      • Jim McCamant
  • Portfolio Overview
    • Acadia (ACAD)
    • Alaunos (TCRT)
    • Alkermes (ALKS)
    • Bicycle (BCYC)
    • BioMarin (BMRN)
    • Celldex (CLDX)
    • Esperion (ESPR)
    • Incyte (INCY)
    • Ionis (IONS)
    • Madrigal (MDGL)
    • Myovant (MYOV)
    • Pacira (PCRX)
    • Precigen (PGEN)
    • Sangamo (SGMO)
    • Skye Bioscience (SKYE)
    • Vaxart (VXRT)
    • Viking (VKTX)
  • Contact Us
  • $0.00 0 items

MTSL Issue 848

MTSL Issue 848 (dated 3/16/17) of Medical Technology #Stock Letter from BioInvest includes #Biotech Sector Analysis & updates: #ANTH #ESPR #IONS #XON #MDCO #OGXI #PCRX

To access this post, you must have an active subscription to the Medical Technology Stock Letter. Please login if you are a current subscriber. Thank you.

Post navigation

Previous post: MTSL Issue 847
Next post: The Medicines Company (MDCO) Fourier Is Actually More Positive For Inclisiran Than Before
ABOUT
About BioInvest
Medical Technology Stock Letter
Subscribe to MTSL
Free MTSL Issue
Disclaimer
Privacy Policy
Testimonials

Login / Logout
LOGIN
Login to My Account
CONNECT
Contact Us
LinkedIn
X
PUBLICITY
Publicity
Media Inquiries
SEARCH
© 2025 BioInvest
  • My Account
  • Search
  • Cart 0